Medicatieveiligheid
Farmaceutische patiëntenzorg
- Universiteit Amsterdam Universitair Medisch Centrum
- Promovendus Selma En-Nasery
- Promoters Jacqueline Hugtenburg
- Co-Promoters Fatma Karapinar, Pierre Bet
- Jaar 2019-2025/2026
KNMP stelt wetenschappelijk onderzoek voorop. Hier kunt u de meest recente onderzoeken vinden.
Er zijn4resultaten gevonden
Medicatieveiligheid
Optimizing therapy in patients suffering from statin-intolerance: n=1 trials.
- Universiteit Erasmus Medisch Centrum Rotterdam
- Promovendus Ruben Mijnster
- Promoters Hugo van der Kuy
- Co-Promoters Melvin Lafeber Jeanine Roeters-van Lennep
- Jaar 2024-2028
My research focuses on the occurence of nocebo-effects in statin-intolerant. We try to identify patients who are statin-intolerant and that suffer from these effects. We hope that by identifying patients affected by the nocebo effect and allowing them to experientially understand its impact through an N=1 study design, they will experience fewer side effects from their statin treatment. This may help prevent the need to switch to expensive PCSK9 inhibitors.
Medicatieveiligheid
Improving pharmaceutical care for hospitalized patients
- Universiteit Erasmus Medisch Centrum Rotterdam
- Promovendus Sarah Wilkes
- Promoters Hugo van der Kuy
- Co-Promoters Rianne Zaal
- Jaar 2022-2026
Cost benefit analysis clinical medication reviews. Follow up of interventions from clinical pharmacists. Medication information needs of hospitalized patients.
Medicatieveiligheid
Improving pharmaceutical care for hospitalized patients
- Universiteit Erasmus Medisch Centrum Rotterdam
- Promovendus Sarah Wilkes
- Promoters Hugo van der Kuy
- Co-Promoters R.J. Zaal
- Jaar 2022-2026
- Cost benefit analysis clinical medication reviews
- Follow up of interventions from clinical pharmacists.
- Medication information needs of hospitalized patients.